General background paper

Transfusion

Volumn 36, Issue 7, 1996, Pages 628-632

  Thomas, M J G ^a   Desmond, M J ^a   Gillon, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; BACTERIUM CONTAMINATION; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONFERENCE PAPER; DISEASE TRANSMISSION; IMMUNITY; BACTEREMIA; BLOOD BANK; COMPARATIVE STUDY; FORECASTING; HUMAN; IMMUNOPATHOLOGY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROTOZOAL INFECTION; REVIEW; RISK; VIRUS INFECTION;

BACTEREMIA; BLOOD BANKS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; FORECASTING; HUMANS; IMMUNE SYSTEM DISEASES; PROTOZOAN INFECTIONS; RISK; VIRUS DISEASES;

EID: 0030195304     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36796323062.x     Document Type: Conference Paper

References (61)

1. AutologousTransfusion. In: Walker RH, ed. Technical manual. 10th ed. Arlington: American Association of Blood Banks, 1990:433.
2. Messmer K. Hemodilution - possibilities and safety aspects. Acta Anaesthesiologica Scandinavia 1988;32(Suppl 89):49-53.
3. Messmer K, Sunder-Plassman L, Klovekorn W, Holper K. Circulatory significance of hemodilution: Theological changes and limitations. Adv Microcirculation 1972;4:1-77.
4. Hint H. The pharmacology of dextran and physiological background of the clinical use of rheomacrodex. Acta Anaesthesia Belgica 1986;19:119-38.
5. Dodd RY. Adverse consequences of blood transfusion: Quantitative risk estimates. In: Nance ST, ed. Blood supply: risks, perceptions and prospects for the future. Bethesda: American Association of Blood Banks, 1994:1-24.
6. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992;32:27-30.
7. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement with autologous or homologous blood transfusion. Transfusion 1991;31:212-7.
8. De Waal LP. Immunomodulating effects of blood transfusion: mechanism and clinical implications. ISBT Abstracts 1994:183-4.
9. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32:517-24.
10. Fernandez MC, Gottlieb M, Menitove JE. Blood transfusion and postoperative infection in orthopedic patients. Transfusion 1992;32:318-22.
11. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-33.
12. Dzik WH. Effects on recipients of exposure to allogeneic donor leukocytes. J Clin Apher 1994;9:135-8.
13. Waymack JP, Robb E, Alexander JW. Effect of transfusion on immune function in a traumatised animal model. II. Effect on mortality rate following septic challenge. Arch Surg 1987;122:935-9.
14. Waymack JP, Warden GD, Alexander JW, et al. Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis. J Surg Res 1987;42:528-35.
15. Tartter PI, Maidman DC. Allogeneic blood transfusions suppress immunity and increase mortality in a septic rat model. Surg Res Commun 1989;5(S):30.
16. Richards C, Kolins J, Trindade CD. Autologous transfusion-transmitted Yersinia enterocolitica. JAMA 1992;268:1541-2.
17. Friedman BA, Oberman HA, Chadwick AR, Kingdon K. The maximum surgical blood order schedule and surgical blood use in United States. Transfusion 1976;17:163-8.
18. Nicholls MD. Autologous blood transfusion - 1989. Med J Australia 1988;149:515-7.
19. Spence RK, Cernaianu AC. Pharmacological agents as adjuncts to bloodless vascular surgery. Semin in Vasc Surg 1994;7:114-20.
20. Murphy WG, Davies MJ, Eduardo A. The haemostatic response to surgery and trauma. Brit J Anaes 1993;70:205-13.
21. Kobrinsky NL, Letts M, Patel LR, et al. 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery: a randomised, double-blinded control trial. Ann Intern Med 1987;107:446-50.
22. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomised trial. N Engl J Med 1986;314:1402-6.
23. Cattaneo M, Mannucci PM. Desmopressin and blood loss after cardiac surgery. Lancet 1993;342:812.
24. Bidstrup BP, Royston D, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary by-pass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72
25. Patrassi GM, Viero M, Sartori MT, et al. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 1994;34:507-11.
26. Smith O, Hazelhurst G, Brozovic B, et al. Impact of aprotinin on blood transfusion requirements in liver transplantation. Transfusion Med 1993;3:97-102.
27. Orchard MA, Goodchild CS, Prentice CRM, et al. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Brit J Haem 1993;85:533-41.
28. Tartter PI, Driefuss RM, Malon AM, et al. Relationship of postoperative septic complications and blood transfusions in patients Crohn's disease. Am J Surg 1988;155:43-8.
29. Rosemurgy AS, Hart MB, Murphy CG, et al. Infection after surgery; association with blood transfusion. Am Surg 1992;58:104-7.
30. Simchen E, Raz R, Stein H, Danon Y. Risk factors for infection in fracture war wounds (1973 and 1982 wars, Israel). Milit Med 1991;156:520-7.
31. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986;152:479-82.
32. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988;75:789-92.
33. Nichols RL, Smith JW, Klein DB, et al. Risks of infection after penetrating abdominal trauma. N Engl J Med 1984;311:1065-70.
34. Dawes LG, Aprahamian C, Condon RE, Malangoni MA. The risk of infection after colon surgery. Surgery 1986;100:796-803.
35. Bock M, Grevers G, Koblitz M, et al. Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer. Acta Otolargngol (Stockh) 1990;110:155-60.
36. Blumberg N, Chuang-Stein C, Heal JM. The relationship of blood transfusion, tumour staging, and cancer recurrence. Transfusion 1990;30:291-4.
37. Tanter PJ. The association of perioperative blood transfusion with colorectal cancer recurrence. J Clin Apher 1994;9:135-8.
38. Busch ORC, Marquet RL, Hopp WIM, Jeekel J. Colorectal cancer recurrence and perioperative blood transfusions: a critical reappraisal. Semin Surg Onc 1994;10:195-9.
39. Velagapudi SR, Frydenberg M, Oesterling JE, et al. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology 1994;43:821-7.
40. Bordin J, Bardossy L, Blajchman M. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of leukodepletion. Blood 1994;84:344-8.
41. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993;33:754-65.
42. Blumberg N, Heal JM. Perioperative blood transfusion and colorectal cancer recurrence. Transfusion 1994;34:450-1.
43. Ford CD, Gillette JW, Handrahan DL, Koehler CS. Transfusion and second malignancy. Transfusion 1994;34:63-5.
44. Heiss MM, Jauch KW, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: a randomised study of autologous versus homologous blood transfusion in colorectal cancer. Proc Am Soc Clin Onc 1992;503.
45. Blumberg N, Heal JM. Transfusion and host defences against cancer recurrence and infection. Transfusion 1989;29:236-45.
46. Tartter PI, Barron DM. Unnecessary blood transfusions in elective colorectal cancer surgery. Transfusion 1985;25:113-5.
47. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90.
48. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusion in coronary artery bypass surgery. Transfusion 1992;32:458-64.
49. Renner SW. The use of Q-Probes in modifying transfusion practice. Arch Pathol Lab Med 1994;118:438-41.
50. Julius CJ, Purchase KS, Isham BE. Patterns of autologous blood use in elective orthopedic surgery: does the availability of autologous blood change transfusion behaviour? Vox Sang 1994;66:171-5.
51. Paul Gann Blood Safety Act, Health and Safety Code Section 1645. State of California, USA.
52. Goldfinger D, Haimowitz M. Controversies in transfusion medicine: is autologous blood transfusion worth the cost? Pro. Transfusion 1994;34:75-8.
53. Zuck TF. Legal liability for transfusion injury in the acquired immune deficiency syndrome era. Pathol Lab Med 1990;114:309-15.
54. Giordano GF, Dockery J, Wallace BA, et al. An autologous blood program co-ordinated by a regional centre: a 5-year experience. Transfusion 1991;31:509-12.
55. Guidelines for autologous transfusion. I. Pre-operative autologous donation. BCSH Transfusion Task Force. Transfusion Med 1993;3:307-16.
56. Widmann FK, ed. Standards for Blood Banks and Transfusion Services. 15th ed. Bethesda: American Association of Blood Banks, 1993.
57. Jenson LS, Anderson AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
58. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
59. Davis RW. Autologous blood transfusion. Med J Aust 1992;157:717.
60. Mercuriali F, Inghilleri G, Biffi E, et al. The potential role of oxygen-carrying products in autologous blood transfusion protocols. Atr Cells, Blood Subs, and Immob, Biotech. 1994;22:245-51.
61. Blood substitutes, physiological basis of efficacy. Winslow RM, Vandegriff KD, Intaglietta M, eds. Boston; Birkhauser:1995 ISBN 0-8176-3804-0.